Junior Executive
CurrentBharat Biotech International Limited (BBIL), as per its credit rating report, is engaged in the manufacture of vaccines. The key products in the company’s vaccine segment are OPV, TCV, RV, rabies vaccine, Japanese encephalitis (JE) vaccine, and pentavalent vaccine. While OPV was a key revenue contributor for BBIL over the years, the company started deriving the majority of its revenues from RV and TCV following a healthy ramp-up in these markets. BBIL is also working on a chikungunya vaccine and Covaxin. It has a manufacturing facility in Hyderabad.